Status:
RECRUITING
Artificial Intelligence in Functional Imaging for Individualized Treatment of Head and Neck Squamous Cell Carcinoma Patients
Lead Sponsor:
Charite University, Berlin, Germany
Collaborating Sponsors:
Helmholtz-Zentrum Dresden-Rossendorf
Max-Delbrück-Centrum Berlin
Conditions:
HNSCC
Eligibility:
All Genders
18+ years
Brief Summary
The two curative treatment modalities for patients with HNSCC - primary chemoradiation (CRT) or primary surgery (often combined with postoperative (C)RT) - are both associated with serious side effect...
Eligibility Criteria
Inclusion
- All patients older than 18 years with diagnosed HNSCC, attending the Department of Radiooncology and Radiotherapy or the Department of Oral and Maxillofacial Surgery at Charité for a treatment with curative intension ( R(C)T or primary surgery / combined).
- All patients received as pretherapeutic diagnostic method a 18F-Fluorodesoxyglucose (FDG) positron emission tomography (PET) imaging
Exclusion
- Patients with HNSCC who cannot be treated in a curative approach
- Patients with HNSCC treated in a curative approach but unable to receive FDG PET imaging before start of treatment
- Data from patients who have withdrawn their study consent
Key Trial Info
Start Date :
December 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05192655
Start Date
December 1 2021
End Date
December 1 2026
Last Update
February 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Radiooncology and Radiotherapy, Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum
Berlin, Germany, 13353